Related Experiment Video
Updated: Jun 13, 2026
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Novel therapies in peripheral T-cell lymphomas
Hilary M O'Leary1, Kerry J Savage
1Department of Medical Oncology, British ColumbiaCancer Agency, 600 West 10th Avenue, Vancouver,British Columbia, Canada.
Current Hematologic Malignancy Reports
|April 29, 2010
Summary
Peripheral T-cell lymphomas (PTCLs) have a poor prognosis, with current treatments often leading to relapse. Novel targeted agents are being developed to improve outcomes for these rare cancers.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Peripheral T-cell lymphomas (PTCLs) represent a rare and heterogeneous group of hematologic malignancies.
- These cancers are characterized by a very poor prognosis and high rates of relapse.
- Current treatment strategies, often adapted from aggressive B-cell lymphomas, show suboptimal efficacy.
Purpose of the Study:
- This review focuses on novel therapeutic agents for PTCLs.
- It aims to discuss emerging treatment approaches currently under evaluation.
- The goal is to highlight advancements that may improve patient outcomes.
Main Methods:
- Review of current literature on PTCLs.
- Analysis of novel targeted agents and treatment strategies.
- Synthesis of information on molecular biology and pathogenesis.
Main Results:
- Existing treatments for PTCLs have limited efficacy and high relapse rates.
- An improved understanding of PTCLs' molecular biology is driving the development of new therapies.
- Novel targeted agents show promise for improving outcomes.
Conclusions:
- Novel targeted agents represent a promising avenue for improving PTCL treatment.
- Further research and clinical evaluation are crucial for these new approaches.
- Targeted therapies may offer better outcomes for patients with PTCLs.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...